DESAFIANDO LOS LÍMITES DEL RIESGO DE RECURRENCIA EN EL CÁNCER DE MAMA INCIPIENTE CON HR POSITIVO O HER2 NEGATIVO DE ALTO RIESGO Dra. Joyce A. O’Shaughnessy:

https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?page=1&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260625_12222926_#transcript-download-es Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer Authors: Joyce A. O’Shaughnessy, MD; Priya Rastogi, MD; Seth Wander, MD, PhD https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?page=3&uac=148436CN&src=mkmcmr_driv_il_mscpedu_260625_&subtitle-lang-code=es